Bioactive compounds of red wine production waste: health effects and benefits

Authors

DOI:

https://doi.org/10.66636/gmj.v1.i3.a191

Keywords:

polyphenols, cardiovascular disease, resveratrol, grape pomace, grape by-products, wine by products, red wine, french paradox, endothelial function, antioxidant, flavonoids

Abstract

Cardiovascular disease remains the leading cause of global mortality, and there is continued interest in dietary compounds that reduce oxidative stress, chronic inflammation, endothelial dysfunction, and atherosclerotic progression. Red wine has been associated with a lower risk of cardiovascular disease — a phenomenon known as the "French paradox" — and most of its proposed benefits are attributed to polyphenolic constituents rather than ethanol. During vinification, large amounts of grape pomace, seeds, and skins are produced, and these winery by-products contain high concentrations of the same bioactive compounds found in wine. This narrative review summarises the evidence regarding the cardiovascular benefits of red wine polyphenols and wine production waste. Key bioactive constituents include quercetin, catechins, anthocyanins, flavonoids, resveratrol, and phenolic acids, which exhibit antioxidant, anti-inflammatory, anti-platelet, and vasoprotective actions. At the molecular level, they inhibit low-density lipoprotein oxidation, suppress NF-κB signalling and pro-inflammatory cytokine production, enhance endothelial nitric oxide synthase activity, and improve nitric oxide bioavailability. Evidence also indicates that red wine polyphenols influence gut microbiota composition and confer vascular protection via epigenetic and mitochondrial signalling pathways, extending their influence beyond direct radical scavenging. Despite promising preclinical and observational findings, translation into clinical practice remains limited by inconsistent dosing strategies, variable bioavailability, and confounding effects of ethanol exposure. Future research should focus on standardised clinical trials of dealcoholised wine and purified polyphenol extracts from grape by-products to identify safe, evidence-based cardiovascular interventions.

Keywords: red wine; polyphenols; cardiovascular disease; resveratrol; grape pomace; French paradox; endothelial function; wine by-products; antioxidant; flavonoids

References

1. Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med. 2018;378(25):e34. https://doi.org/10.1056/NEJMoa1800389

2. Snopek L, Mlcek J, Sochorova L, Baron M, Hlavacova I, Jurikova T, et al. Contribution of red wine consumption to human health protection. Molecules. 2018;23(7):1684. https://doi.org/10.3390/molecules23071684

3. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992;339(8808):1523–1526. https://doi.org/10.1016/0140-6736(92)91277-f

4. Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342:d671. https://doi.org/10.1136/bmj.d671

5. Chiva-Blanch G, Urpi-Sarda M, Llorach R, et al. Differential effects of polyphenols and alcohol of red wine on the expression of adhesion molecules and inflammatory cytokines related to atherosclerosis. Circ Res. 2012;111(10):1013–1023. https://doi.org/10.1161/CIRCRESAHA.112.275636

6. Del Bo' C, Bernardi S, Cherchi S, et al. A single dose of a polyphenol-rich grape extract improves endothelial function in healthy individuals. Nutr Metab Cardiovasc Dis. 2021;31(3):948–956.

7. Diasamidze K, Kalandia A, Jafaridze I, Vanidze M. Saperavi wine by-products as a sustainable source of bioactive polyphenols: phenolic composition and antioxidant potential. Georgian Med J. 2026;1(2). https://doi.org/10.66636/gmj.v1.i2.a121

8. Joyner PM. Protein adducts and protein oxidation as molecular mechanisms of flavonoid bioactivity. Molecules. 2021;26(16):5102. https://doi.org/10.3390/molecules26165102

9. Castaldo L, Narváez A, Izzo L, et al. Red wine consumption and cardiovascular health. Molecules. 2019;24(19):3626. https://doi.org/10.3390/molecules24193626

10. Peña-Portillo GC, Acuña-Nelson SM, Bastías-Montes JM. From waste to wealth: exploring the bioactive potential of wine by-products — a review. Antioxidants (Basel). 2024;13(8):992. https://doi.org/10.3390/antiox13080992

11. Gál R, Halmosi R, Gallyas F, et al. Resveratrol and beyond: the effect of natural polyphenols on the cardiovascular system: a narrative review. Biomedicines. 2023;11(11):2888. https://doi.org/10.3390/biomedicines11112888

12. Liu Y, Luo J, Peng L, Zhang Q, Rong X, Luo Y, et al. Flavonoids: potential therapeutic agents for cardiovascular disease. Heliyon. 2024;10(12):e32563. https://doi.org/10.1016/j.heliyon.2024.e32563

13. Romain C, Gaillet S, Carillon J, Vidé J, Ramos J, Izard JC, et al. Vineatrol and cardiovascular disease: beneficial effects of a vine-shoot phenolic extract in a hamster atherosclerosis model. J Agric Food Chem. 2012;60(44):11029–11036. https://doi.org/10.1021/jf303549t

14. Mokni M, Hamlaoui S, Karkouch I, Amri M, Marzouki L, Limam F, et al. Resveratrol provides cardioprotection after ischemia/reperfusion injury via modulation of antioxidant enzyme activities. Iran J Pharm Res. 2013;12(4):867–875.

15. dos Santos KC, Braga CP, Barbanera PO, Seiva FRF, Fernandes Junior A, Fernandes AAH. Cardiac energy metabolism and oxidative stress biomarkers in diabetic rat treated with resveratrol. PLoS One. 2014;9(7):e102775. https://doi.org/10.1371/journal.pone.0102775

16. Brown K, Theofanous D, Britton RG, Aburido G, Pepper C, Sri Undru S, et al. Resveratrol for the management of human health: how far have we come? A systematic review of resveratrol clinical trials to highlight gaps and opportunities. Int J Mol Sci. 2024;25(2):747. https://doi.org/10.3390/ijms25020747

17. Bonnefont-Rousselot D. Resveratrol and cardiovascular diseases. Nutrients. 2016;8(5):250. https://doi.org/10.3390/nu8050250

18. Lopes JdC, Madureira J, Marçaca FMA, Cabo Verde S. Grape pomace: a review of its bioactive phenolic compounds, health benefits, and applications. Molecules. 2025;30(2):362. https://doi.org/10.3390/molecules30020362

19. Godos J, Romano GL, Gozzo L, et al. Resveratrol and vascular health: evidence from clinical studies and mechanisms of actions related to its metabolites produced by gut microbiota. Front Pharmacol. 2024;15:1368949. https://doi.org/10.3389/fphar.2024.1368949

20. Cooper KA, Chopra M, Thurnham DI. Wine polyphenols and promotion of cardiac health. Nutr Res Rev. 2004;17(1):111–129. https://doi.org/10.1079/NRR200482

21. Piano MR, Marcus GM, Aycock DM, et al. Alcohol use and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2025;152(1):e7–e21. https://doi.org/10.1161/CIR.0000000000001341

22. European Association for the Study of the Liver. EASL policy statement: reducing alcohol harms. 2023. https://easl.eu/publication/easl-policy-statement-reducing-alcohol-harms/

Downloads

Published

08/22/2026

How to Cite

Gedikoglu, S., Alghalibi, H., Efe Ozdas, C., Bilek, G., & Diasamidze, K. (2026). Bioactive compounds of red wine production waste: health effects and benefits. Georgian Medical Journal, 1(3). https://doi.org/10.66636/gmj.v1.i3.a191

Similar Articles

1 2 3 4 5 > >> 

You may also start an advanced similarity search for this article.